JP2023533970A - 肺癌を検出するための組成物及び方法 - Google Patents

肺癌を検出するための組成物及び方法 Download PDF

Info

Publication number
JP2023533970A
JP2023533970A JP2023501081A JP2023501081A JP2023533970A JP 2023533970 A JP2023533970 A JP 2023533970A JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023533970 A JP2023533970 A JP 2023533970A
Authority
JP
Japan
Prior art keywords
polypeptide
target
biomarker
lung cancer
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023501081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533970A5 (enExample
Inventor
ジョゼフ チャールズ セドラック，
ローラ テレサ ボートリン，
ダニエル パーカー セイラム，
エミリー スーザン ウィン－ディーン，
ダニエル グーセンライトナー，
アンソニー デイビッド クービロン，
Original Assignee
マーシー バイオアナリティクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マーシー バイオアナリティクス， インコーポレイテッド filed Critical マーシー バイオアナリティクス， インコーポレイテッド
Publication of JP2023533970A publication Critical patent/JP2023533970A/ja
Publication of JP2023533970A5 publication Critical patent/JP2023533970A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023501081A 2020-07-08 2021-07-08 肺癌を検出するための組成物及び方法 Pending JP2023533970A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063049538P 2020-07-08 2020-07-08
US63/049,538 2020-07-08
PCT/US2021/040971 WO2022011197A1 (en) 2020-07-08 2021-07-08 Compositions and methods for detection of lung cancer

Publications (2)

Publication Number Publication Date
JP2023533970A true JP2023533970A (ja) 2023-08-07
JP2023533970A5 JP2023533970A5 (enExample) 2024-07-17

Family

ID=79552705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023501081A Pending JP2023533970A (ja) 2020-07-08 2021-07-08 肺癌を検出するための組成物及び方法

Country Status (8)

Country Link
US (1) US20240011993A1 (enExample)
EP (1) EP4179106A4 (enExample)
JP (1) JP2023533970A (enExample)
KR (1) KR20230044429A (enExample)
CN (1) CN116113708A (enExample)
AU (1) AU2021305652A1 (enExample)
CA (1) CA3188377A1 (enExample)
WO (1) WO2022011197A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12480940B2 (en) 2018-05-17 2025-11-25 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
CN114875144B (zh) * 2022-04-02 2026-04-17 及智(苏州)医学技术有限公司 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
WO2023212315A2 (en) * 2022-04-29 2023-11-02 Meso Scale Technologies, Llc. Methods for detecting and isolating extracellular vesicles
US20240309453A1 (en) * 2023-03-13 2024-09-19 Northwestern University Diagnosis of acute and chronic lung diseases by quantifying spink1 level
CN116855605B (zh) * 2023-06-13 2024-06-25 中国医学科学院北京协和医院 Aoc1作为区分卵巢透明细胞癌和高级别浆液性癌的标志物的应用
CN116593693B (zh) * 2023-07-11 2023-09-19 四川大学华西医院 一种磁性适配体探针、其制备方法和应用及迁移体富集方法
CN117741153A (zh) * 2023-11-07 2024-03-22 南京联笃生物科技有限公司 一种用于多癌种早期筛查、诊断和/或监测的生物标志物及应用
KR102752505B1 (ko) * 2024-04-23 2025-01-16 주식회사 이롬 다중오믹스 기반 폐암 진단용 바이오 마커 패널 및 이를 이용한 폐암 진단방법
CN118460477B (zh) * 2024-07-09 2024-11-05 苏州唯思尔康科技有限公司 一种特别适于内载有效货物的外泌体支架蛋白及其应用
CN119798401B (zh) * 2024-12-30 2025-10-10 常州因普迈生物科技有限公司 基于pdzk1ip1蛋白的多肽、抗体及其应用
CN120102887B (zh) * 2025-05-10 2025-07-25 浙江格物致知生物科技有限公司 一种检测肺癌的联检产品及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012508577A (ja) * 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
JP2013521502A (ja) * 2010-03-01 2013-06-10 カリス ライフ サイエンシズ ルクセンブルク ホールディングス セラノーシスのためのバイオマーカー
US20160003835A1 (en) * 2012-10-23 2016-01-07 Caris Life Sciences Switzerland Holdings S.A.R.L. Aptamers and uses thereof
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013361323B2 (en) * 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
EP3268476B1 (en) * 2015-03-09 2025-07-16 Caris Science, Inc. Oligonucleotide probes and uses thereof
GB201511546D0 (en) * 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
GB201518655D0 (en) * 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
JP7137474B2 (ja) * 2016-03-15 2022-09-14 メルサナ セラピューティクス，インコーポレイティド ＮａＰｉ２ｂ標的化抗体－薬物コンジュゲート及びその使用方法
EP3740567A4 (en) * 2018-01-18 2022-03-09 Nanosomix Inc. DETECTION OF EXOSOMES AND EXOSOMAL BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS
CN108148912B (zh) * 2018-03-08 2021-10-08 四川大学 肿瘤的生物标志物、应用和肿瘤检测试剂盒
CN110954703A (zh) * 2019-12-27 2020-04-03 杭州迪相实业有限公司 一种同时检测外泌体内蛋白和rna、外泌体膜蛋白的方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012508577A (ja) * 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
JP2013521502A (ja) * 2010-03-01 2013-06-10 カリス ライフ サイエンシズ ルクセンブルク ホールディングス セラノーシスのためのバイオマーカー
US20160003835A1 (en) * 2012-10-23 2016-01-07 Caris Life Sciences Switzerland Holdings S.A.R.L. Aptamers and uses thereof
JP2016506716A (ja) * 2012-10-23 2016-03-07 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー アプタマーおよびその使用
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法

Also Published As

Publication number Publication date
AU2021305652A1 (en) 2023-02-23
EP4179106A4 (en) 2024-10-23
CN116113708A (zh) 2023-05-12
EP4179106A1 (en) 2023-05-17
CA3188377A1 (en) 2022-01-13
WO2022011197A1 (en) 2022-01-13
US20240011993A1 (en) 2024-01-11
KR20230044429A (ko) 2023-04-04

Similar Documents

Publication Publication Date Title
JP2023533970A (ja) 肺癌を検出するための組成物及び方法
JP7344973B2 (ja) 標的実体を検出するためのシステム、組成物、及び方法
US20240368701A1 (en) Compositions and methods for cancer detection
US8632980B2 (en) Gene expression markers for prediction of patient response to chemotherapy
US20250223649A1 (en) Compositions and methods for detection of lung cancer
JP2023510911A (ja) 卵巣癌を検出するための組成物及び方法
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
US20250297317A1 (en) Compositions and methods for detection of liver cancer
US20250043357A1 (en) Compositions and methods for detection of esophageal cancer
US20240377401A1 (en) Compositions and methods for detection of prostate cancer
EP4374172A2 (en) Compositions and methods for detection of breast cancer
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
US20240369560A1 (en) Compositions and methods for detection of pancreatic cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260121

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260420